Pliant Therapeutics say-on-pay vote fails; Krognes appointed to board

PLIANT THERAPEUTICS, INC.

Non-binding say-on-pay vote failed: 23,479,353 for, 28,329,655 against, 10,277 abstain.
Steve Krognes appointed as Class III director and Audit Committee chair; receives option for 53,528 shares vesting over 3 years.
Board size increased from 10 to 11 members to accommodate Krognes.
Deloitte & Touche LLP ratified as auditor for FY2024: 56,628,368 for, 10,853 against, 62,998 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.